[Skip navigation] FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule

Tentative Approvals - March 2005

  ANDA Number Generic Drug Name Applicant Tentative Approval Date
1 76-520 FENOFIBRATE TABLETS 54 MG, 107 MG, AND 160 MG   PAR PHARMACEUTICAL 3/3/2005 
2 76-575 TOPIRAMATE CAPSULES 15 MG AND 25 MG   TEVA PHARMACEUTICALS USA 3/9/2005 
3 77-065 TERBINAFINE HYDROCHLORIDE TABLETS 250 MG (BASE)   GEDEON RICHTER LTD. 3/10/2005 
4 76-799 PIOGLITAZONE HYDROCHLORIDE TABLETS 15 MG (BASE), 30 MG (BASE), AND 45 MG (BASE)   ALPHAPHARM PTY, LTD. 3/15/2005 
5 76-415 OLANZAPINE TABLETS 2.5 MG, 5 MG, 7.5 MG, 10 MG, 15 MG, AND 20 MG   TEVA PHARMACEUTICALS USA 3/24/2005 
6 76-846 AMLODIPINE BESYLATE TABLETS 2.5 MG (BASE), 5 MG (BASE), AND 10 MG (BASE)   TEVA PHARMACEUTICALS USA 3/24/2005 
7 76-866 OLANZAPINE TABLETS 2.5 MG, 5 MG, 7.5 MG, 10 MG, 15 MG, AND 20 MG   MYLAN PHARMACEUTICALS INC. 3/25/2005 
8 76-826 LEVOFLOXACIN OPHTHALMIC SOLUTION 0.5%   HI-TECH PHARMACAL CO., INC. 3/28/2005 
9 75-959 OCTREOTIDE ACETATE INJECTION (MULTIPLE DOSE VIALS) 0.2 MG/ML AND 1.0 MG/ML   SICOR PHARMACEUTICALS, INC. 3/28/2005 
10 75-957 OCTREOTIDE ACETATE INJECTION 0.05 MG/ML, 0.1 MG/ML, AND 0.5 MG/ML   SICOR PHARMACEUTICALS, INC. 3/28/2005 
11 76-904 RISPERIDONE ORAL SOLUTION 1 MG/ML   ROXANE LABORATORIES, INC. 3/30/2005 

Back to Top     Back to Approvals

Date created: April 8, 2005

horizonal rule